Pompey, NY, United States of America

Felicie Georgette Colette Denet

This inventor holds 2 USPTO granted patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Felicie Georgette Colette Denet. Retrieved from https://idiyas.com/inventor/felicie-georgette-colette-denet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Felicie Georgette Colette Denet: Innovator in Saponin Purification

Introduction

Felicie Georgette Colette Denet is a notable inventor based in Pompey, NY (US). She has made significant contributions to the field of saponin purification, holding 2 patents that focus on innovative methods and applications.

Latest Patents

Her latest patents include advancements in saponin extracts, specifically those containing at least 93% QS-21 main peak and 0.25-3% 2018 component by UV absorbance at 214 nm. These patents detail methods for making said extracts and their use as vaccine adjuvants, highlighting their importance in medical applications.

Career Highlights

Felicie is associated with GlaxoSmithKline Biologicals SA, where she continues to push the boundaries of research and development in her field. Her work has been instrumental in enhancing the efficacy of vaccine formulations through her innovative approaches to saponin purification.

Collaborations

Felicie has collaborated with esteemed colleagues such as Ahmad Taimour Baig and Juan Jose Diaz Garcia, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Felicie Georgette Colette Denet stands out as a pioneering inventor in the realm of saponin purification, with her patents paving the way for advancements in vaccine technology. Her contributions are vital to the ongoing development of effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…